Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
UPEXI, INC. (GRVI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/05/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
10/03/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
10/02/2023 |
8-K
| Quarterly results |
09/28/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
08/18/2023 |
8-K
| Quarterly results |
08/14/2023 |
8-K
| Termination of a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
08/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
07/31/2023 |
8-K
| Quarterly results |
07/07/2023 |
4
| MARSHALL ALLAN (CEO) has filed a Form 4 on UPEXI, INC.
Txns:
| Bought 100 shares
@ $2.275, valued at
$227.5 Bought 7,893 shares
@ $2.388, valued at
$18.8k
Bought 23,952 shares
@ $2.432, valued at
$58.3k
Bought 24,000 shares
@ $2.387, valued at
$57.3k
Bought 24,000 shares
@ $2.257, valued at
$54.2k
|
|
06/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/09/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/25/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/23/2023 |
4
| MARSHALL ALLAN (CEO) has filed a Form 4 on UPEXI, INC.
Txns:
| Bought 22,776 shares
@ $3.4132, valued at
$77.7k
|
|
05/19/2023 |
10-Q/A
| Quarterly Report for the period ended March 31, 2023 [amend] |
05/18/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
05/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/15/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
05/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
05/10/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/09/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
04/19/2023 |
8-K
| Quarterly results |
04/14/2023 |
8-K
| Quarterly results |
03/20/2023 |
4
| MARSHALL ALLAN (CEO) has filed a Form 4 on UPEXI, INC.
Txns:
| Bought 4,334 shares
@ $4.3272, valued at
$18.8k
Bought 4,572 shares
@ $4.4793, valued at
$20.5k
Bought 4,095 shares
@ $4.4139, valued at
$18.1k
|
|
03/10/2023 |
SC 13G
| Norstrud Andrew James reports a 5.6% stake in UPEXI, INC. |
03/10/2023 |
SC 13G/A
| MARSHALL ALLAN reports a 23.9% stake in UPEXI, INC. |
03/10/2023 |
SC 13G/A
| Salkind Gene reports a 13.6% stake in UPEXI, INC. |
03/06/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
02/24/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
02/24/2023 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ... |
02/10/2023 |
8-K
| Quarterly results |
01/11/2023 |
4
| MARSHALL ALLAN (CEO) has filed a Form 4 on UPEXI, INC.
Txns:
| Bought 10,000 shares
@ $3.75, valued at
$37.5k
Bought 2,725 shares
@ $3.66, valued at
$10k
Bought 4,578 shares
@ $3.59, valued at
$16.4k
|
|
12/15/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
12/13/2022 |
4
| MARSHALL ALLAN (CEO) has filed a Form 4 on UPEXI, INC.
Txns:
| Bought 12,000 shares
@ $4.11, valued at
$49.3k
|
|
|
|
|